Daily disposable contact lenses as a platform for ocular drug delivery of cyclosporine A

• Autorzy: Michałkiewicz Ola , Nowak Iwona , Nowak Rafał , Rykowska Iwona

Identyfikatory

DOI

10.37190/ppmp/172794

• Języki publikacji: EN

Abstrakty

EN

Ophthalmic drug delivery is an important area of research that aims to improve the efficacy and convenience of treatment for various eye conditions. There are multiple ways in which drugs can be delivered to the eye, including eye drops, ointments, gels, and inserts. The most prevalent way of administering medication to the eye is through eye drops. They are easy to use and can be self-administered by patients. Nonetheless, eye drops have the disadvantage of being prone to removal by tears, which may result in insufficient drug absorption and reduced effectiveness. Irregular use of active substances can exacerbate the disease, resulting in prolonged treatment with questionable efficacy. Soft contact lenses that serve as ophthalmic drug delivery systems (DDS) can become a viable substitute for traditional treatments. These polymeric lenses can be embedded with various active compounds, some of which are not readily soluble in water or physiological fluids. One such drug is Cyclosporine A (CyA), an immunosuppressant with a high molecular weight and hydrophobic properties, chronically used to treat dry eye syndrome (DES). The article discusses the development of a method for modifying Hilafilcon B contact lenses obtained from drugstores with Cyclosporine A (CyA). The drug was administered to the lenses using an immersion technique, and the process parameters were monitored to control drug release efficiency and profile. The drug release was measured in an Artificial Lacrimal Fluid (ALF) buffer, mimicking tear fluid with a pH of 7.9. The stability of CyA in this buffer was assessed. For the parameters used, the best drug application and release profile was achieved by immersing the contact lenses for 24 hours at 25°C in a CyA solution containing 20 μg/ml of the active substance and adding 5 mg/ml of Vitamin E.

Słowa kluczowe

EN

contact lens; cyclosporine A; vitamin E; drug delivery systems; dry eye syndrome

• Wydawca: Oficyna Wydawnicza Politechniki Wrocławskiej
• Czasopismo: Physicochemical Problems of Mineral Processing
• Rocznik: 2023
• Tom: Vol. 59, iss. 4
• Strony: art. no. 172794
• Opis fizyczny: Bibliogr. 44 poz., fot., tab., wykr.

Twórcy

autor

Michałkiewicz Ola

• Adam Mickiewicz University, Faculty of Chemistry, ul. Uniwersytetu Poznanskiego 8, 61-614 Poznan, Poland

autor

Nowak Iwona

• Adam Mickiewicz University, Faculty of Chemistry, ul. Uniwersytetu Poznanskiego 8, 61-614 Poznan, Poland

autor

Nowak Rafał

• Department of Ophthalmology, Military Institute of Medicine, ul. Szaserów 128, 04-141, Warsaw, Poland

autor

Rykowska Iwona

• Adam Mickiewicz University, Faculty of Chemistry, ul. Uniwersytetu Poznanskiego 8, 61-614 Poznan, Poland

Bibliografia

• LANIER, O., MANFRE, M., BAILEY, C., 2021. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations. AAPS PharmSciTech (Vol. 22, Issue 3).
• BARABINO, S., CHEN, Y., CHAUHAN, S., DANA, R., 2012. Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease. In Progress in Retinal and Eye Research (Vol. 31, Issue 3, pp. 271–285).
• CHAUDHARI, P., GHATE, V. M., LEWIS, S. A., 2021. Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics. European Journal of Pharmaceutics and Biopharmaceutics, 161, 80–99.
• CHOI, J. H., LI, Y., JIN, R., SHRESTHA, T., CHOI, J. S., LEE, W. J., MOON, M. J., JU, H. T., CHOI, W., YOON, K. C., 2019. The Efficiency of Cyclosporine A-Eluting Contact Lenses for the Treatment of Dry Eye. Current Eye Research, 44(5), 486–496.
• DATTA, D., ROY, G., GARG, P., VENUGANTI, V. V. K., 2022. Ocular delivery of cyclosporine A using dissolvable microneedle contact lens. Journal of Drug Delivery Science and Technology, 70.
• DE OLIVEIRA, R. C., WILSON, S. E. (2019). Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease. In Clinical Ophthalmology (Vol. 13, pp. 1115–1122). Dove Medical Press Ltd.
• DING, S., 1998. Recent developments in ophthalmic drug delivery. Pharmaceutical Science and Technology Today, 1(8), 328–335.
• DOWNIE, L. E., BANDLITZ, S., BERGMANSON, J. P. G., CRAIG, J. P., DUTTA, D., MALDONADO-CODINA, C., NGO, W., SIDDIREDDY, J. S., WOLFFSOHN, J. S., 2021. BCLA CLEAR-Anatomy and physiology of the anterior eye. Contact Lens and Anterior Eye, 44(2), 132–156.
• FILIPE, H. P., HENRIQUES, J., REIS, P., SILVA, P. C., QUADRADO, M. J., SERRO, A. P., 2016. Contact lenses as drug controlled release systems: A narrative review. Revista Brasileira de Oftalmologia, 75(3), 241–247.
• GAUSE, S., HSU, K. H., SHAFOR, C., DIXON, P., POWELL, K. C., CHAUHAN, A., 2016. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses. Advances in Colloid and Interface Science, 233, 139–154.
• GAYTON, J. L., 2009. Etiology, prevalence, and treatment of dry eye disease. Clinical Ophthalmology, 3, 405–412.
• GLOWACKA, P., RUDNICKA, L., WARSZAWIK-HENDZEL, O., SIKORA, M., GOLDUST, M., GAJDA, P., STOCHMAL, A., BLICHARZ, L., RAKOWSKA, A., OLSZEWSKA, M., 2020. The antiviral properties of cyclosporine. Focus on coronavirus, hepatitis C virus, influenza virus, and human immunodeficiency virus infections. Biology, 9(8), 1–12.
• HOVANESIAN, J. A., NICHOLS, K. K., JACKSON, M., KATZ, J., CHAN, A., GLASSBERG, M. B., SLOESEN, B., KORVES, C., NGUYEN, C., SYNTOSI, A., 2021. Real-world experience with lifitegrast ophthalmic solution (Xiidra®) in the us and canada: Retrospective study of patient characteristics, treatment patterns, and clinical effectiveness in 600 patients with dry eye disease. Clinical Ophthalmology, 15, 1041–1054.
• HUI, A., 2017. Contact lenses for ophthalmic drug delivery. In Clinical and Experimental Optometry (Vol. 100, Issue 5, pp. 494–512). Blackwell Publishing Ltd.
• JEHANGIR, N., BEVER, G., MAHMOOD, S. M. J., MOSHIRFAR, M., 2016. Comprehensive review of the literature on existing punctal plugs for the management of dry eye disease. In Journal of Ophthalmology (Vol. 2016). Hindawi Publishing Corporation.
• KIM, J., PENG, C. C., CHAUHAN, A., 2010. Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E. Journal of Controlled Release, 148(1), 110–116.
• LANG, J. C. (1995). Ocular drug delivery conventional ocular formulations. In Advanced Drug Delivery Reviews (Vol. 16).
• LANIER, O. L., CHRISTOPHER, K. G., MACOON, R. M., YU, Y., SEKAR, P., CHAUHAN, A., 2020. Commercialization challenges for drug eluting contact lenses. Expert Opinion on Drug Delivery, 17(8), 1133–1149.
• LE LE BOURLAIS, C. :, ACAR, L., ZIA, H., SADO, P. A., NEEDHAM, T., LEVERG¢, R., 1997. Ophthalmic Drug Delivery Systems Recent Advances.
• LEMP, M. A., BAUDOUIN, C., BAUM, J., DOGRU, M., FOULKS, G. N., KINOSHITA, S., LAIBSON, P., MCCULLEY, J., MURUBE, J., PFLUGFELDER, S. C., ROLANDO, M., TODA, I. (2007). The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007). Ocular Surface, 5(2), 75–92.
• LI, C. C., CHAUHAN, A., 2006. Modeling ophthalmic drug delivery by soaked contact lenses. Industrial and Engineering Chemistry Research, 45(10), 3718–3734.
• MAHALING, B., KATTI, D. S., 2016. Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo. International Journal of Pharmaceutics, 501(1–2), 1–9.
• MAULVI, F. A., CHOKSI, H. H., DESAI, A. R., PATEL, A. S., RANCH, K. M., VYAS, B. A., SHAH, D. O., 2017. pH triggered controlled drug delivery from contact lenses: Addressing the challenges of drug leaching during sterilization and storage. Colloids and Surfaces B: Biointerfaces, 157, 72–82.
• MAULVI, F. A., SONI, T. G., SHAH, D. O., 2016a. A review on therapeutic contact lenses for ocular drug delivery. In Drug Delivery (Vol. 23, Issue 8, pp. 3017–3026). Taylor and Francis Ltd.
• MAULVI, F. A., SONI, T. G., SHAH, D. O., 2016b. A review on therapeutic contact lenses for ocular drug delivery. Drug Delivery, 23(8), 3017–3026.
• MCNAMARA, N. A., POLSE, K. A., BRAND, R. J., GRAHAM, A. D., CHAN, J. S., MCKENNEY, C. D., 1999. Tear Mixing Under a Soft Contact Lens: Effects of Lens Diameter. Am. J. Opthalmol, 127, 659–665.
• MOSHIRFAR, M., PIERSON, K., HANAMAIKAI, K., SANTIAGO-CABAN, L., MUTHAPPAN, V., PASSI, S. F., 2014. Artificial tears potpourri: A literature review. In Clinical Ophthalmology (Vol. 8, pp. 1419–1433). Dove Medical Press Ltd.
• MOSTAFA, M., AL FATEASE, A., ALANY, R. G., ABDELKADER, H., 2023. Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases. Pharmaceutics, 15(6), 1746.
• MUN, J., MOK, J. W., JEONG, S., CHO, S., JOO, C. K., HAHN, S. K., 2019. Drug-eluting contact lens containing cyclosporine-loaded cholesterol-hyaluronate micelles for dry eye syndrome. RSC Advances, 9(29), 16578–16585.
• MUSGRAVE, C. S. A., FANG, F., 2019. Contact lens materials: A materials science perspective. In Materials (Vol. 12, Issue 2). MDPI AG.
• MUTSCHLER, E., MALINOWSKA, B., DROŹDZIK, M., KOCIĆ, I., PAWLAK, D., GEISSLINGER, G., KROEMER, H. K., MENZEL, S., RUTH, P., GROTTHUS, B., 2016. Mutschler farmakologia i toksykologia: podręcznik. MedPharm Polska.
• PENG, C. C., BURKE, M. T., CHAUHAN, A., 2012. Transport of topical anesthetics in vitamin e loaded silicone hydrogel contact lenses. Langmuir, 28(2), 1478–1487.
• PENG, C. C., CHAUHAN, A., 2011. Extended cyclosporine delivery by silicone-hydrogel contact lenses. Journal of Controlled Release, 154(3), 267–274.
• PENG, C. C., KIM, J., CHAUHAN, A., 2010. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing Vitamin E diffusion barriers. Biomaterials, 31(14), 4032–4047.
• PENG, C.-C., & CHAUHAN, A. (2011). Extended cyclosporine delivery by silicone–hydrogel contact lenses. Journal of Controlled Release, 154(3), 267–274.
• PERIMAN, L. M., MAH, F. S., KARPECKI, P. M., 2020. A review of the mechanism of action of cyclosporine a: The role of cyclosporine a in dry eye disease and recent formulation developments. In Clinical Ophthalmology (Vol. 14, pp. 4187–4200). Dove Medical Press Ltd.
• RYKOWSKA, I., NOWAK, I., NOWAK, R., 2021. Soft contact lenses as drug delivery systems: A review. In Molecules (Vol. 26, Issue 18). MDPI.
• SEMP, D. A., BEESON, D., SHEPPARD, A. L., DUTTA, D., & WOLFFSOHN, J. S. (2023). Artificial Tears: A Systematic Review. In Clinical Optometry (Vol. 15, pp. 9–27). Dove Medical Press Ltd.
• STEVENSON, D., TAUBER, J., REIS, B. L., 2000. Efficacy and Safety of Cyclosporin A Ophthalmic Emulsion in the Treatment of Moderate-to-severe Dry Eye Disease A Dose-Ranging, Randomized Trial The Cyclosporin A Phase 2 Study Group. In Ophthalmology (Vol. 107).
• TONG, A. Y., PASSI, S. F., GUPTA, P. K., 2020. Clinical Outcomes of Lifitegrast 5% Ophthalmic Solution in the Treatment of Dry Eye Disease. Eye & Contact Lens, 46, S20–S24.
• WHITE, D. E., ZHAO, Y., OGUNDELE, A., FULCHER, N., ACS, A., MOORE-SCHILTZ, L., KARPECKI, P. M. (2019). Real-world treatment patterns of cyclosporine ophthalmic emulsion and lifitegrast ophthalmic solution among patients with dry eye. Clinical Ophthalmology, 13, 2285–2292.
• XU, J., XUE, Y., HU, G., LIN, T., GOU, J., YIN, T., HE, H., ZHANG, Y., TANG, X., 2018. A comprehensive review on contact lens for ophthalmic drug delivery. Journal of Controlled Release, 281, 97–118.
• ZAKI, M., PARDO, J., CARRACEDO, G., 2019. A review of international medical device regulations: Contact lenses and lens care solutions. In Contact Lens and Anterior Eye (Vol. 42, Issue 2, pp. 136–146). Elsevier B.V.
• ROZIER, A., MAZUEL, C., GROVE, J., PLAZONNET, B., 1989. Gelrite: A novel, ion-activated, in-situ gelling polymer for opthalmic vehicles. Effect on bioavailability of timolol. International Journal of Pharmaceutics (Vol. 57, pp. 163-168)

Uwagi

Opracowanie rekordu ze środków MNiSW, umowa nr SONP/SP/546092/2022 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2024).